Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of Two Cases

By sjmartinez • May 10, 2025

Shah VD, Bansil S, Reed JP. Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of Two Cases. Cureus. 2025 Apr 8;17(4):e81877. doi: 10.7759/cureus.81877. PMID: 40342434; PMCID: PMC12060583.

Tags: autoimmune disease, clinical trial inclusion, Fellow, General Internal Medicine, Hematology/Oncology, immune checkpoint inhibitor, immune related adverse events, Olive View DoM, Publications, Resident, rheumatologic disease

Changing Clinician Behavior in Geriatrics: Point-of-Care Alerts for Prostate-Specific Antigen Screening

Duong N, Lee JY, Peprah Y, Brown T, Linder JA, Doctor JN, Meeker D, Fox CR, Goldstein NJ, Persell SD, Petito LC. Changing Clinician Behavior[...]

Centralization of Lung Cancer Screening and Adherence to First Follow-up Assessment: The Veterans Health Administration Experience

Benjamin LN, Núñez ER, Chen L, Motwani Y, Yuan A, Vangala S, Slatore CG, Wiener RS, Elashoff DA, Yano EM, Washington DL, Mangione CM. Centralization[...]

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations

Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB. Methylation[...]